Table 3.
Study Phase | Investigator | Time period | Cell lines | Treatments |
---|---|---|---|---|
Phase I | G.S. | Oct 2017-Feb 2018 (4 mo) | HC5,6 | 1,2,6,11,12,13,19,20,21,22 |
Phase II | G.S. | Aug 2018-May 2019 (10 mo) | HC1,2,3, SURF1_1,2,3 | 1,2,3,4,10,14,15,18 |
Phase III | G.S. | Feb 2019-April 2019 (3 mo) | HC1,2,4 | 1,2,5,6,16,17 |
Phase IV | J.M. | May 2019-Oct 2019 (6mo) | HC1,2 | 1,7,8,9 |
Phase V | A.S.M. | Oct 2020-June 2021 (8mo) | HC1,2,3, SURF1_1,2,3 | 1,5 |
Five phases conducted by different investigators with varying study lengths, cell lines, treatments, and exposures.